Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS??? EQUITY (Details)

v3.20.4
STOCKHOLDERS’ EQUITY (Details) - USD ($)
1 Months Ended 12 Months Ended
Jan. 19, 2021
Dec. 16, 2020
Dec. 08, 2020
Dec. 03, 2020
Nov. 03, 2020
Sep. 09, 2020
Aug. 14, 2020
Jun. 03, 2020
May 06, 2020
Dec. 15, 2019
Sep. 27, 2019
Jan. 25, 2021
Jan. 17, 2020
Nov. 27, 2019
Oct. 30, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Jan. 31, 2021
Nov. 12, 2020
Sep. 28, 2018
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Preferred stock, authorized                               5,000,000 10,000,000        
Preferred stock, par value (in Dollars per share)                               $ 0.0001 $ 0.0001        
Preferred stock, shares Issued                                      
Preferred stock, shares outstanding                                      
Conversion of aggregate of shares     979,361                                    
Aggregate of shares     195,881                                    
Aggregate of shares     15,093                                    
Certificate of designation series A preferred stock             5,000,000                            
Percentage purchase price             25.00%                            
Purchase price (in Dollars)             $ 6.00                            
Effective interest rate             25.00%                            
Effective conversion price (in Dollars)             $ 6.00                            
Stockholder debt term             1 year                            
Percentage of premium     25.00%                                    
Reverse stock split, description         the Board of Directors of the Company approved a one-for-three reverse stock split of the Company’s authorized and outstanding common stock, effective November 13, 2020 (the “Reverse Stock Split”).                     All share and per share amounts in the consolidated financial statements and related notes have been retrospectively adjusted to reflect the Exchange Ratio in connection with the Acquisition.          
Common stock, authorized                               116,666,667 116,666,667        
Common stock, par value (in Dollars per share)                               $ 0.0001 $ 0.0001        
Price per share (in Dollars per share)                               $ 5.58          
Purchase price per share (in Dollars per share)     $ 6.00                                    
Amount of shares to purchase by stock option (in Dollars)     $ 26,762,000                                    
Stock options to purchase                               568,006 225,001      
Stock options exercise price (in Dollars per share)                               $ 7.39 $ 9.75      
Restricted stock purchase               1,000,000                          
2018 Equity Incentive Plan [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Common stock reserved for issuance                               3,333,334          
Investor [Member] | Securities Purchase Agreement [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Number of shares issued                           253,600 206,000            
Gross proceeds from initial closing (in Dollars)                     $ 6,065,000                    
Net proceeds from second closing (in Dollars)                             $ 515,000            
Net proceeds from third closing (in Dollars)                           $ 634,000              
Investor [Member] | Registration Rights Agreement [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Description of liquidated damages payable                               The amount of liquidated damages payable to an Investor is 1.0% of the aggregate amount invested by such Investor for each 30-day period, or pro rata portion thereof, during which the default continues. To date the Company has paid $60,650 and accrued $19,053 in liquidated damages.          
Placement Agent [Member] | Securities Purchase Agreement [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Aggregate cash fee (in Dollars)                               $ 721,400          
Percentage of gross proceeds                               10.00%          
Reimbursement of transaction expenses (in Dollars)                               $ 40,000          
Number of warrants to purchase                               288,560          
Securities Purchase Agreement [Member] | Placement Agent [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Warrants exercise price (in Dollars per share)                               $ 3.25          
Energy Capital [Member] | Loan And Security Agreement [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Debt principal and interest outstanding amount (in Dollars)                               $ 10,563,104          
Number of equity instruments convertible                               1,408,414          
Convertible Preferred Stock [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Preferred stock, shares outstanding     2,350,390                                    
Conversion of aggregate of shares     979,361                                    
Aggregate of shares     195,881                                    
Aggregate of shares     15,093                                    
Convertible Notes Payable [Member] | Other Financing Agreements [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Debt principal and interest outstanding amount (in Dollars)                               $ 3,933,767          
Number of equity instruments convertible                               524,505          
Preferred Stock [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Preferred stock, authorized                               10,000,000          
Preferred stock, par value (in Dollars per share)                               $ 0.0001          
Preferred stock, shares Issued                               5,000,000          
Preferred stock, shares outstanding                               5,000,000          
Common Stock [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Common stock, authorized                                       116,666,667  
Common stock outstanding                                       19,796,029  
Common stock, par value (in Dollars per share)                                         $ 0.0001
Number of shares issued           120,000       120,000                      
Common Stock [Member] | Individual Lender [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Number of shares issued                     46,893                    
Warrant [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Number of warrants to purchase                 231,543                        
Warrants exercise price (in Dollars per share)                 $ 7.50   $ 9.75     $ 9.75 $ 9.75            
Description of warrant rights                 On May 6, 2020, the Company’s Board granted (i) an aggregate of 47,917 Warrants with an exercise price of $7.50 per share and a grant date fair value of $1.00 per share, and (ii) an aggregate of 9,793 Warrants with an exercise price of $6.39 per share and a grant date fair value of $1.71 per share.                         
Warrant fair value (in Dollars per share)                     $ 1.00     $ 1.03 $ 1.05            
Stock options to purchase                 231,543                        
Expected weighted average vesting period                 5 years             3 years          
Warrants to purchase shares                     1,498,603     50,726 41,206            
Warrant [Member] | Minimum [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Warrant fair value (in Dollars per share)                 $ 1.40                        
Warrant [Member] | Maximum [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Warrant fair value (in Dollars per share)                 $ 2.37                        
Warrant [Member] | Securities Purchase Agreement [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Number of warrants to purchase                               1,879,803          
Warrants exercise price (in Dollars per share)                               $ 9.16          
Weighted-average contractual remaining life                               2 years 2 months 12 days          
Warrant [Member] | Securities Purchase Agreement [Member] | Minimum [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Warrants exercise price (in Dollars per share)                               $ 0.03          
Warrant [Member] | Securities Purchase Agreement [Member] | Maximum [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Warrants exercise price (in Dollars per share)                               $ 9.75          
Warrant [Member] | Individual Lender [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Warrants exercise price (in Dollars per share)                     $ 0.03                    
Warrant fair value (in Dollars per share)                     $ 7.47                    
Warrants to purchase shares                     46,893                    
Equity Option [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Agreement, description                     On September 27, 2019, pursuant to the terms of Severance Agreements, 225,001 incentive stock options with deferred distribution were promised to two former employees of the Company pursuant to the 2018 Plan (both employees participated in the restricted stock purchase offers (“RSUs”) discussed below).                    
Stock options to purchase                 499,674       6,542                
Stock-based compensation expense (in Dollars)                               $ 514,866          
Options term                 10 years     10 years 5 years                
Stock options exercise price (in Dollars per share)                 $ 6.39       $ 7.50                
Weighted average grant-date fair value (in Dollars per share)                 $ 2.25       $ 2.37                
Stock compensation expense (in Dollars)                               1,397,000 $ 435,000        
Unrecognized compensation expense (in Dollars)                               $ 233,000          
Weighted-average contractual remaining life                               1 year 3 months 18 days          
Subsequent Event [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Warrants exercise price (in Dollars per share)                                     $ 9.75    
Warrants to purchase shares                                     96,269    
Subsequent Event [Member] | Equity Option [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Stock options to purchase                       90,000                  
Stock options exercise price (in Dollars per share)                       $ 12.72                  
Weighted average grant-date fair value (in Dollars per share)                       $ 5.72                  
Securities Purchase Agreement [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Agreement, description             the Company entered into securities purchase agreements (the “2020 Purchase Agreements”) with certain purchasers (the “2020 Investors”), which provided for the sale of an aggregate of $4,435,000 ($4,483,749 after payment of offering expenses) and the exchange for debt of $265,779 of the Company’s Series A Convertible Preferred Stock (the “Series A Preferred”) at a purchase price of $2.00 per share (the “Purchase Price”) (the “Offering”). On August 14, 2020 and August 27, 2020, pursuant to the 2020 Purchase Agreements, the Company issued an aggregate of 2,350,390 shares of Series A Preferred to the Investors (collectively the “2020 Closing”). In connection with the 2020 Closing, Eric Brock, the Company’s Chief Executive Officer purchased 157,500 shares of Series A Preferred.                            
Securities Purchase Agreement [Member] | Investor [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Number of shares issued                     2,426,000                    
Restricted Stock Units (RSUs) [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Weighted-average contractual remaining life                               1 year 3 months          
Weighted average grant-date fair value (in Dollars per share)                                   $ 0.64      
Stock compensation expense (in Dollars)                               $ 3,150,000          
Unrecognized compensation expense (in Dollars)                               $ 5,250,000          
Restricted stock purchase                                   126,160      
Shares options issued non-vested                               625,000          
Weighted average grant-date fair value of exercise price (in Dollars per share)                               $ 8.40          
Vesting period                               2 years   2 years      
Restricted stock                                   136,161      
Expenses of stock (in Dollars)                                 71,789        
Restricted Stock Units (RSUs) [Member] | Subsequent Event [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Description of restricted stock units Effective January 19, 2021, (i) Mr. Bushey will have the right to receive 500,000 RSU Shares (375,000 RSU Shares vested as of December 31, 2020 and 125,000 RSU Shares on which the Compensation Committee accelerated vesting), which RSU Shares will be issued on June 3, 2022 pursuant to Mr. Bushey’s deferral election, and (ii) 500,000 RSU shares will be canceled.                                        
Public Offering [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
shares issued       5,000,000                                  
Common stock, par value (in Dollars per share)       $ 0.0001                                  
Over-Allotment Option [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Number of shares issued   750,000   750,000                                  
Proceeds from sale of units (in Dollars)   $ 4,200,000                                      
Over-Allotment Option [Member] | Investor [Member] | Securities Purchase Agreement [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Number of shares issued                     400,000                    
Purchase price per share (in Dollars per share)                     $ 2.50                    
Proceeds from sale of units (in Dollars)                     $ 12,500,000                    
Proceeds from sale of additional units (in Dollars)                     $ 2,500,000                    
Description of transaction                     Each Unit consists of one share of Common Stock and one-half of one warrant to purchase one share of Common Stock at an exercise price of $3.25 per share for a period commencing six months and ending 36 months after the closing date (the “Investor Warrants”).                    
Gross proceeds from initial closing (in Dollars)                     $ 1,000,000                    
Consultant [Member] | Restricted Stock Units (RSUs) [Member]                                          
STOCKHOLDERS’ EQUITY (Details) [Line Items]                                          
Stock compensation expense (in Dollars)                               $ 30,357 $ 50,599